SK Plasma, which is constructing a plasma fractionation plant in Indonesia, announced that it will fully commence its contract manufacturing organization (CMO) business for blood products in Indonesia.
News & Resources
| [Apr10] SK Plasma launches blood product manufacturing in Indonesia with 2026 target | |||
| Name | KPBMA | ||
|---|---|---|---|
| Registration date | 2025/04/11 | ||
| Links(files, etc.) | |||
|
|
|||
| Prev | [Apr09] D&D Pharmatech's U.S. subsidiary unveils AI-powered single-cell genetic analysis platform 'SCADE' | ||
| Next | [Apr10] Celltrion gains Australian approval for three biosimilars in ophthalmology and bone disease | ||